In mantle cell lymphoma (MCL) the MCL-International Prognostic Index (MIPI) is a better predictor of event-free and overall survival than International Prognostic Index (IPI) in patients receiving intensive 1st line treatment including ASCT

Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

Bibtex

@article{7f0988d5e5f64e87a54beda33879b98e,
title = "In mantle cell lymphoma (MCL) the MCL-International Prognostic Index (MIPI) is a better predictor of event-free and overall survival than International Prognostic Index (IPI) in patients receiving intensive 1st line treatment including ASCT",
author = "C. Geisler and E. Elonen and A. Kolstad and A. Laurell and C Sundstrom and J. Delabie and Mats Ehinger and M-L Karjalainen-Lindsberg and E. Ralfkiaer and P. Brown",
note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology, (Lund) (013030000)",
year = "2009",
language = "English",
volume = "94",
pages = "0971",
journal = "Haematologica-The Hematology Journal",
issn = "1592-8721",
publisher = "Ferrata Storti Foundation",

}